Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.62
Delayed Data
As of Jun 24
 +0.02 / +3.33%
Today’s Change
0.29
Today|||52-Week Range
1.59
-11.43%
Year-to-Date

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.55 - 0.63
Volume127,980
Average volume (3 months)59,488
Market cap$87.2M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+26.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book46.46

Competitors

 Today’s
change
Today’s
% change
EPIXESSA Pharma Inc-0.03-1.02%
SBBPStrongbridge Biophar...-0.16-4.13%
MSTXMast Therapeutics In...-0.01-1.47%
OHRPOHR Pharmaceutical I...+0.01+0.36%
Data as of 4:06pm ET, 06/24/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Partner Offers

Search for Jobs